CommercialPrior AuthHigh impact
Magnetic Resonance Imaging (MRI) of the Prostate - (Effective Date - 2026-10-15) 6.01.46
Excellus BlueCross BlueShield·Urology, Oncology, Radiology·Radiology (x-rays) & Imaging
Effective date
Oct 15, 2026
We identified it
Jul 16, 2026
Summary
Excellus BlueCross BlueShield has issued a comprehensive new medical policy (6.01.46) effective October 15, 2026, establishing detailed coverage criteria for prostate MRI across five clinical scenarios: suspected prostate cancer, initial workup/staging, restaging/recurrence, and active surveillance follow-up. The policy specifies strict age and PSA thresholds, risk stratification requirements, and explicitly states that serial MRIs for PSA monitoring alone and MR guidance for needle placement are NOT medically necessary. Billing teams must implement prior authorization requirements based on these specific clinical criteria to avoid claim denials.
Action Required
Before October 15, 2026: (1) Billing and Prior Authorization teams must update systems to require clinical documentation matching one of five policy criteria (Suspected Cancer, Initial Workup/Staging, Restaging/Recurrence, Active Surveillance Follow-up, or PIN Management) before authorizing prostate MRI claims. (2) Providers must document: patient age, current PSA value (within 6 months), DRE findings, risk stratification category (per NCCN guidelines for workup/staging cases), biopsy history if applicable, and which specific criterion is met. (3) Reject all requests for serial MRI monitoring of elevated PSA without concurrent clinical indication (DRE changes, biopsy results, or active surveillance protocol). (4) Reject all requests for MR-guided needle placement for prostate biopsy as not medically necessary. (5) Update encounter forms and authorization templates to include NCCN risk stratification checklist for workup/staging cases. (6) Train prior auth staff on age/PSA thresholds: ages 40-75 with PSA >3 ng/ml plus high-risk features (Criterion I.A), ages 45-75 with PSA >3 or suspicious DRE (Criterion I.B), ages >75 with PSA ≥4 or suspicious DRE (Criterion I.C). (7) Flag claims for medical review if documentation is incomplete. Failure to implement these requirements will result in increased claim denials and potential member appeals.